Advances for Medical Professionals

Advances for Medical Professionals

Medical News for Patients & Visitors

Medical News for Patients & Visitors

Outcomes & Quality Reports

Outcomes & Quality Reports

246

Advances in Oncology

NewYork-Presbyterian

Advances in Oncology

NewYork-Presbyterian Establishes the William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma

NewYork-Presbyterian has established the William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma led by renowned experts in neuro-oncology from Columbia University Medical Center and Weill Cornell Medicine. The Center is focused on pursuing groundbreaking research and providing advanced treatments for glioblastoma and other deadly brain cancers. Made possible by a major gift from Mr. Rhodes, a Life Trustee of NewYork-Presbyterian since 1992, the program was created to honor Louise Tilzer-Rhodes, who passed away from glioblastoma in 2016.

“Thanks to the generosity of Mr. Rhodes, we have an opportunity to make tremendous strides in our understanding and treatment of glioblastomas,” says Steven J. Corwin, MD, President and CEO of NewYork-Presbyterian. “NewYork-Presbyterian is committed to becoming the world’s leader in the fight against this deadly disease.”

“Glioblastoma has had a profound impact on my family and countless others,” says Mr. Rhodes. “It’s so important that we bring together and empower the brightest minds to bring new therapies — and one day, a cure — to patients.”

The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at NewYork-Presbyterian aims to advance care for glioblastoma and other brain cancers via a three-pronged approach: providing multidisciplinary, research-driven patient care, with a focus on genomic and precision medicine; emphasizing translational research to rapidly bring promising new therapies from the bench to the bedside; and educating the next generation of clinicians and scientists with new fellowships created to expose young physicians to the most cutting-edge work being done in the field.

William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma – Leadership

Jeffrey N. Bruce, MD
Co-Director, Brain Tumor Center
Director, Bartoli Brain Tumor Research Laboratory
NewYork-Presbyterian/Columbia University Medical Center

Andrew B. Lassman, MD
Chief, Division of Neuro-Oncology
Department of Neurology
Co-Director, Brain Tumor Center
NewYork-Presbyterian/Columbia University Medical Center

Howard A. Fine, MD
Founding Director, Brain Tumor Center
NewYork-Presbyterian/Weill Cornell Medical Center

Rohan Ramakrishna, MD
Surgical Neuro-Oncologist, Brain Tumor Center
NewYork-Presbyterian/Weill Cornell Medical Center

Related Publications


Oncology

Prestigious SPORE Grant to Advance Prostate Cancer Care

Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute to improve the detection and treatment of aggressive prostate cancer (PCa).
Oncology

Renowned Surgeon Leads Columbia Breast Surgery Program

A skilled surgeon and renowned researcher in locally advanced and metastatic breast cancer, Dr. Roshni Rao provides expertise in early stage breast cancer, innovative localization techniques, and tumescent mastectomy.
Oncology

Comprehensive Programs Address Brain and CNS Metastases

Columbia’s Central Nervous System Metastases Clinic (CNSMets) was recently established to coordinate and advance the treatment of brain, leptomeningeal, skull base, spinal cord, and spine metastases.

Related Publications